Good Agricultural and Collecting Practices (GACP) Certification Granted To Plena Global

Good Agricultural and Collecting Practices (GACP) Certification Granted To Plena Global

Victoria, BC, Canada, September 14, 2020  — Plena Global Holdings Inc. (the “Company” or “Plena Global”), a leading international operator and a licensed producer of pharmaceutical-grade medical cannabis, has been granted Good Agricultural and Collecting Practices (“GACP”) certification by CUMCS (Control Union Medical Cannabis Standard) for its Econnabis subsidiary in Colombia after successfully meeting the CUMCS’s guidelines for quality and consistency on the cultivation and harvest of medical cannabis.

“This international certification recognizes our efforts and reinforces our position as the leading B2B medical cannabis producer in Latin America.” Stated Richard Zwicky, CEO of Plena Global, continuing “Receiving this highly sought-after certification on the first attempt, and for all areas of our facility, which is uncommon.  Our facility in Colombia has now been recognized as producing the finest quality and highest-grade medical cannabis in the world.”

As Ron Hudcosky, Head of Quality stated, “at Plena Global we have built a Quality Management System aligned with ISO 9001:2015 that encompasses cultivation through extraction, and ultimately in our derivatives and final products.  This is a culture we have built, ensuring we meet the highest quality standards globally, which is reflected in the quality of our products.”

This new GACP certification further expands Plena Global’s sizable capacity to export pharmaceutical-grade cannabis products to international markets.

“GACP certification extends beyond certifying the operational practices, it embodies the philosophy of our organization and also recognizes our dedication to sustainability,” continued Stefan Meyer, Plena Global’s Global Head of Strategy, “and this philosophy stretches from patients to the community and our socially responsible practices.”

Control Union Certifications, a Dutch based leading worldwide certification body, is a global leader in medical cannabis certification. The CUMCS certification standard is based on GACP guidelines of The World Health Organization (WHO), the GACP Guidelines of the European Medicines Agency, Guidelines of the Dutch Government for Cannabis for Medical Use, and the International Standard for Good Agriculture Practice. CUMCS certified cultivation sites are compliant with these GACP Guidelines. CUMCS examines the consistency of medicinal plants, tracking of plants from cloning to harvest, and the quality of process for propagation, growing, cultivation, drying and packaging, among other areas.  The use of Agrotrac, Plena Global’s proprietary software, was specifically highlighted by CUMCS as increased technology supporting compliance through traceability of the varieties, management of the cultivation steps, and inventories of plant materials at each stage of the lifecycle.

“Obtaining GACP certification is recognition of Plena Global’s strict adherence to the highest international operating standards. CUMCS has provided us with an independent review and certification of the quality of our operations and the rigor of our procedures, highlighting the talent and dedication of our highly trained, world-class team. Being awarded this highest level of quality certification recognizes the value we bring to the global medical cannabis supply chain,” said Richard Zwicky.

About Plena Global

  • Production costs below $0.07 / gram; the lowest medical cannabis production costs in the industry for the highest quality product.  
  • The company on track to produce in excess of 18,000 kg of GACP cannabis in 2020, and over 50,000 kg THC & CBD in 2021
  • Plena Global aligns with ISO 9001:2015  systems and earns GACP certification for the production of medical cannabis at its facility in Colombia

Plena Global is a global B2B and B2W cannabis production company, headquartered in Victoria, British Columbia, Canada with a focus on supplying medical-grade cannabis products to licensed producers, pharmaceutical companies, manufacturers and distributors worldwide. With landholdings strategically located in Colombia, South America, Plena Global can scale cultivation and production operations in optimal growing environments.

For more information about Plena Global, visit its website at

Cautionary Statement on Forward Looking Information

Certain information in this press release constitutes “forward-looking information” within the meaning of applicable securities laws. Forward-looking information is neither historical fact nor assurance of future performance. Instead, such information is based on our current beliefs, expectations, assumptions and analyses made by us regarding the future of our business, future plans and strategies, our operational results and other future conditions. Forward-looking information relates to, among other things, our future financial performance, financial condition, liquidity, levels of activity, performance, prospects, growth, goals or achievements or other future events. In some cases, forward looking information can be identified by the use of forward looking terminology such as “plans”, “assumes”, “targets”, “expects”, or “does not expect”, “is expected”, “an opportunity exists”, “budget”, “scheduled”, “estimates”, “outlook”, “forecasts”, “projection”, “prospects”, “strategy”, “intends”, “anticipates”, “does not anticipate”, “believes”, or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might”, “will”, “will be taken”, “occur” or “be achieved”.  

Despite a careful process to prepare and review the forward-looking information, there can be no assurance that the underlying opinions, estimates, and assumptions will prove to be correct. All forward-looking information contained in this press release is given as of the date hereof and is based upon the opinions and estimates of management and information available to management as at the date hereof. Except as required by law, the company disclaims any obligation to update or revise any forward-looking information, whether as a result of new information, events or otherwise. The forward-looking information contained in this press release is expressly qualified by this cautionary statement.